Home › Chronic Progressive Multiple Sclerosis › Tennessee
Chronic Progressive Multiple Sclerosis clinical trials in Tennessee
4 studies for Chronic Progressive Multiple Sclerosis are looking for participants at sites in Tennessee.
Cities in Tennessee
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Neurology Clinic, P.C., Cordova
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Sep 23, 2026 · NCT07299019A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Neurology Clinic, P.C., Cordova
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Sep 22, 2026 · NCT07067463A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Neurology Clinic PC, Cordova
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Sep 8, 2026 · NCT07609719A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Neurology Clinic PC, Cordova
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 29, 2026 · NCT07225504From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.